Thorlef Spickschen, Director at Clovis Oncology, Inc. (CLVS), sold 4,500 shares at $60.02 ($270K) on 2018-04-09, disclosed to the SEC on 2018-04-09.
Open-market sale of $270k CLVS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2018-03-09 | $277K | — | Filing → |
| CLVS | SELL | 2018-02-23 | $270K | — | Filing → |
| CLVS | SELL | 2018-01-09 | $292K | — | Filing → |